Insulet Corporation (PODD) Stock Analysis

    $PODD · HEALTHCARE · MEDICAL DEVICES

    Insulet (PODD), a MEDICAL DEVICES company, has a market capitalization of about $10.09B and trades at 38.4x trailing earnings.

    Price

    $145.50

    Market cap

    $10.09B

    P/E ratio

    38.4x

    Dividend yield

    —

    About Insulet Corporation

    Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.

    How StockWorthy values PODD

    StockWorthy forecasts Insulet Corporation's revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from PODD's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.

    Related stocks

    Medtronic PLC$MDTBoston Scientific Corp$BSXGE HealthCare Technologies Inc.$GEHCPenumbra Inc$PEN

    See PODD's Fair Value

    Create a free account to view Insulet Corporation's base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.

    Create Free AccountSign In